Melanocytes derived from pluripotent neural crest cells migrate initially in the dorsolateral pathway between the ectoderm and dermomyotome. To understand the role of speci®c proteins involved in this cell migration, we looked for a cellular model that mimics the in vivo behavior of melanoblasts, and that allows functional studies of their migration. We report here that wild-type embryonic stem (ES) cells are able to follow the ventral and dorsolateral neural crest pathways after being grafted into chicken embryos. By contrast, a mutant ES cell line de®cient for b1 integrin subunits, proteins involved in cell±extracellular interactions, had a severely impaired migratory behavior. Interestingly, ES cells de®cient for Kit, the tyrosine kinase receptor for the stem cell factor (SCF), behaved similarly to wild-type ES cells. Thus, grafting mouse ES cells into chicken embryos provides a new cellular system that allows both in vitro and in vivo studies of the molecular mechanisms controlling dorsolateral migration. q
Introduction
The neural crest of vertebrates is comprised of a transient population of cells and is localized in the dorsal part of the closing neural tube. The neural crest cells are morphologically indistinguishable from each other and are highly pluripotent, capable of giving rise to many cell types (Le Douarin, 1982; Thiery et al., 1982; Serbedzija et al., 1994; Anderson, 1997) . The cells proliferate extensively and follow different routes to reach their ®nal destinations. Initially, truncal neural crest cell derivatives are able to follow two loosely organized streams of cells. Cells in the ventral pathway give rise to the neurons and glia of the peripheral nervous system. In the dorsolateral stream determined neural crest cells migrate to and subsequently penetrate the epidermis where they differentiate into melanocytes.
In the mouse, the full population of melanocytes is derived from only thirty-four founders, as determined by genetic analysis (Mintz, 1967) . The melanoblasts derived from these founders proliferate actively before and during their migration. Melanoblasts migrating in the dorsolateral pathway have been studied using different approaches such as cultures of cells derived from the neural crest, transplantation of the neural tube from a quail or a mouse embryo into a chick embryo, and analysis of melanocyte development of mice carrying a coat color mutation.
In vertebrates, melanoblasts express different markers, including transcription factors such as Mitf, the microphthalmia-associated transcription factor (Mitf); enzymes such as dopachrome tautomerase (encoded at the Dct locus, formerly Trp2/slaty), and cell surface receptors such as Kit (Kit/W), the receptor for the stem cell factor (SCF) (Pavan and Tilghman, 1994; Motro et al., 1991; Jackson et al., 1992; Nakayama et al., 1998) . In the absence of one of these proteins, or of the ligand for c-kit (Steel) , mice have a partial or total lack of hair pigmentation (Steel et al., 1992; Murphy et al., 1992; Hodgkinson et al., 1993) . However, none of these genes are expressed at the time of their determination. In addition, speci®c perturbation of dorsolateral migration is not easy to achieve in vivo, due to the poor accessibility of mouse embryos and the absence of antibodies for many chicken melanoblast proteins.
We looked for a cellular model that can reproduce the in vivo behavior of melanoblasts, and that would allow func-tional studies of their migration, differentiation, and proliferation. The mouse sarcoma cell line S180 are able to follow the ventral pathway of neural crest cells after being grafted into chicken embryos, but S180 cells do not migrate along the dorsolateral pathway (Erickson et al., 1980) . Only S180 cells that ectopically expressed the integrins containing a b 1-chain, a 4b1 and a5b 1, are able to follow the dorsolateral pathway (Beauvais et al., 1995) . However, murine sarcoma S180 cells do not offer a convenient system since these cells are not related to neural crest cell derivatives, are not able to migrate spontaneously in the dorsolateral pathway, and genes cannot easily be inactivated in these aneuploid cells.
Therefore, we decided to test the migratory behavior of cells developmentally upstream of the melanocytic lineage. We chose a cell line that could mimic this migration, murine embryonic stem (ES) cells. These cells are totipotent and are known to express a very large spectrum of genes (Keller et al., 1993) . Several studies involving xenografts between mouse and chicken have shown that the main environmental cues are conserved between mouse and chick embryos (Fontaine-Perus et al., 1995 , 1997 . We thus postulated that ES cells would be responsive to chicken environmental factors. In this study, we show that grafted ES cells follow both the ventral and dorsolateral, neural crest pathways. Furthermore, mutant ES cell line de®cient for b1-chain of the ®bronectin receptor had a severely impaired migratory behavior, whereas Kit-de®cient ES cells behaved similarly to the wild-type ES cells. ES cells thus offer a new cellular system for both in vitro and in vivo studies of the molecular mechanisms controlling dorsolateral migration.
Results

Murine ES cells are able to follow both classical migration pathways of neural crest cells
ES cells were labeled with a¯uorescent marker (CFSE) and grafted into early trunk neural crest cell migratory pathways (Fig. 1A,B) . The migratory behavior of the cells was assessed by ®xing the host embryos 18 h after receiving the graft and then observing them under a confocal scanninḡ uorescence microscope. Murine ES cells were able to migrate in both the ventral and dorsolateral pathways simultaneously (Fig. 1C) . In some cases, an integration of the cells into the ectoderm was observed (data not shown). This intercalation into the ectoderm have certainly been stabilized by homophilic interactions mediated by L-CAM, the chick E-cadherin homologue, present at the cell surface of ectodermal cells of the host, and E-cadherin, expressed on the cytoplasmic membrane of ES cells. Therefore, ES cells seemed to be a suitable model to study neural crest cell migration and, more speci®cally, dorsolateral migration.
To further characterize this model, we examined the fate of the grafted cells in the embryo after a longer period. CFSE was hardly detectable 42 h after the graft. Thus, the lacZ marker was used to follow ES cells in the embryo. Wild-type ES cells were transfected with the p62 plasmid containing lacZ, selected with G418, and ES cells expressing a high level of b -galactosidase were isolated. As a second screening, ES cells were in vitro differentiated and stained with Xgal, and ES cell lines expressing a high amount of b -galactosidase before and after differentiation were kept. The resulting ES cells were grafted into chick embryos and incubated at 388C for 18, 42 and 66 h. lacZexpressing ES cells were recovered at all stages in the chick embryo in the ventral as well as in the dorsolateral pathways (Fig. 2A±C ). These cells migrated farther along the dorsolateral pathway. No cell proliferation was seen in this pathway.
We looked for the ability of grafted genuine ES to differentiate into pigment cell precursors in chick embryos 18 h after the graft. Mitf, the microphthalmia-associated transcription factor, was used as a marker to evaluate the differentiation stage of the grafted ES cells. In situ hybridization experiments revealed that the ES cells started to express at a signi®cant level the Mitf gene in the dorsolateral pathway 18 h after the graft (unpublished results).
ES cells express several molecular markers of melanoblasts
To better understand the molecular basis of the migratory behavior of ES cells, we examined the expression of various melanoblast markers in non-differentiated ES cell culture. Mitf RNA was expressed at a very low level in ES cells. After a long exposure period, Mitf RNA could be detected by northern blot analysis using polyA mRNA (Fig. 3A) , but the protein could not be detected (Fig. 3D) . A 10 nM forskolin treatment has been shown to enhance the expression of Mitf in melanoma cells and melanocytes (Bertolotto et al., 1998) . This treatment was thus applied to the ES cells, but we were still unable to detect the Mitf protein. This result suggested that there is only a small amount of Mitf protein in these cells, if any. The tyrosine kinase receptor Kit was expressed in genuine ES cells and was phosphorylated in the presence of exogenous SCF, its ligand (Fig. 3E ). In contrast, there was no endogenous expression of Steel (Fig. 3B,F) . Finally, expression of the genes encoding for the endothelin receptor type B (Ednrb), the tyrosinase related protein 1 (Tyrp1), the dopachrome tautomerase (Dct), the tyrosinase (Tyr), and the Slug protein (Slugh) was found by reverse transcription±polymerase chain reaction (RT±PCR) in ES cells, while no transcripts corresponding to the gene encoding endothelin 3 (Edn3) or the paired box 3 protein (Pax3) were detected (data not shown).
Kit-de®cient ES cells migrate in the dorsolateral pathway
Analysis of Kit mutant mice suggested that this tyrosine-kinase receptor played a role in migration, survival and/or proliferation of pigment cell precursors throughout their development. However, a direct role of the Kit receptor in early dorsolateral migration was not clearly established. The Kit W-lacZ mutation, which was created by replacing the ®rst exon of Kit with the Escherichia coli lacZ gene using gene targeting technology, is a null allele at the Kit locus (Bernex et al., 1996 (g) is inserted between the neural tube and the somite. The migratory pathways for neural crest cells: one goes ventrally (1); the other one goes dorsolaterally (2). (C) Cells were labeled with a green¯uorescent marker (CFSE) prior to the graft. Embryos were ®xed 18 h after receiving the graft, immunostained with an anti-laminin antibody that recognizes the basal lamina of epithelia of the embryo (red), and analyzed by optical scanning using a confocal scanning¯uorescence microscope. OmA, omphalo-mesenteric artery; S, somite; He, heart; NT, neural tube; No, notochord; Dm, dermomyotome. Scale bar: 15 mm.
b 1 integrin-de®cient ES cells cannot ef®ciently migrate in the dorsolateral pathway of neural crest cells
Cell motility is controlled by the receptors that mediate cell-substrate adhesion. Integrins are the main family of extracellular matrix receptors (Hynes, 1992) . As many as 11 integrin subunits associate with the b1 integrin subunit. In vivo, b 1 integrin is expressed in migrating neural crest cells (Duband et al., 1986) . We have shown previously that a 4b 1 or a 5b 1 are important for dorsolateral migration (Beauvais et al., 1995) . ES cells express a5b 1, a 3b 1, a 6b 1 and avb 1 integrin subunits Coppolino et al., 1997) . To further examine the role of b 1 integrins in cell migration, nullizygous (ItgbI 2 /ItgbI 2 designated hereafter b1 2 =b1 2 b1 2=2 ) and heterozygous
) ES cells were tested for their ability to migrate in chicken neural crest cell pathways. The b 1 1/2 ES cells ( Fig.  5A ) behaved similarly to the wild-type cells (Fig. 1C) . Positive grafted embryos were de®ned as those embryos in which the cells were still present when observed under thē uorescent microscope. Surprisingly, the percentage of positive grafted embryos was greater for the heterozygous (86%) ES cells than for the nullizygous (60%) ES cells (Fig.  5D ). One potential explanation is that nullizygous cells are less able to integrate into the host tissues and thus graft is more easily expulsed by the embryo.
In positive grafted embryos, three types of in vivo ES cell behavior were usually observed: no migration, migration along the ventral pathway and migration along both the ventral and dorsolateral pathways. Non-migrating cells generally remained as tightly aggregated clusters at the graft site (Fig. 5B) .
The main result was that the ability of b 1 2/2 ES cells to migrate in the dorsolateral pathway was severely impaired.
Indeed, only 6% of the embryos grafted with nullizygous cells contained cells migrating in the dorsolateral pathway, compared to 43% for embryos grafted with heterozygous ES cells (Fig. 5D ). However, b1 2/2 ES cells were still able to The blots were loaded either with 20 mg of total RNA or with about 8 mg of polyA RNA. PolyA RNA was used when the signal was not detectable on total RNA and is indicated with an asterisk located on the top right of the band. The size of Mitf, Kit and SCF mRNAs are 5.5, 8.2 and 6.5 kb, respectively. The molecular weights of Mitf and Kit proteins are 55±62 kDa and 145 kDa, respectively. Kit 2/2 ES cells were used as a negative control. The phosphorylation of Kit was followed (E, lane c) after immunoprecipitation of this protein using anti Kit antibodies, and incubation of the membrane with anti-phosphotyrosine 4G10. SCF proteins have molecular weights of 28 and 45 kDa. COS-KLM1 10£ and 1£ correspond to cell extracts (2 different loading volumes) derived from COS cells expressing the transmembrane form of Steel (45 kDa). COS-KLS corresponds to the supernatant of COS cells expressing a soluble form of SCF (28 kDa). These two proteins are indicated by the two arrowheads. Melb-a cells were used as a negative control. migrate ventrally in vivo, although with a lower ef®ciency than the heterozygous ES cells (Fig. 5C ). Two parameters explain this lower ef®ciency. First, 53% of positive grafted embryos grafted with nullizygous ES cells contained nonmigrating cells, compared to 35% for the grafts of heterozygous cells (Fig. 5D) . Second, although the number of grafted cells were similar, the average number of migrating cells in embryos grafted with b 1 1/2 ES cells was about 8 compared to 3 for the b 1 2/2 ES cells. In conclusion, the behavior of b1 2/2 integrin and Kit 2/2 ES cells presented above illustrates the interest of the system for studying the mechanisms controlling the migration of neural crest cells.
b l integrin-de®cient ES cells bind to ®bronectin through RGD-dependent integrins
Fibronectin is the major component of the extracellular matrix in the migration pathways of neural crest cells. 1/2 and b 1 2/2 ES cells were incubated on 10 and 50 mg/ml ®bronectin (Fig. 6 and data not shown, respectively). b 1 2/2 ES cells were able to interact with ®bronectin ( Fig.  6D,E ), though to a lesser extent than b 1 1/2 ES cells (20% reduction, Fig. 6A,B) . In addition, b 1 2/2 ES cells were much less spread, and thus appeared smaller than b 1 1/2 ES ES cells (Fig. 6B,E ).
In the presence of RGDS peptides which compete for binding to the RGD site normally present on ®bronectin (Pierschbacher and Ruoslahti, 1984) , attachment of b 1 2/2 cells to ®bronectin was nearly completely inhibited (Fig.  6D,F) . By contrast, no change in binding ef®ciency was observed for b 1 1/2 cells (Fig. 6A,C) . Fibronectin also binds to cells through cellular proteoglycans (Woods et al., 1993) . One hundred mg/ml heparin was used to compete for binding to proteoglycans. Heparin had no effect on the adhesion of b 1 2/2 ES cells, suggesting that this adhesion was not mediated only by proteoglycans (data not shown). Altogether, these experiments suggested that b 1 2/2 cell adhesion to ®bronectin involved RGD-dependent receptors such as the a vb 3 and a vb 5 integrins. Furthermore, these integrins were suf®cient to allow ventral migration of b 1-de®cient cells, whereas the dorsolateral migration was more dependent upon b 1 integrins.
Discussion
Melanocytes are derived from the neural crest. The pigment cell precursors follow the dorsolateral pathway between the ectoderm and the dermomyotome. This pathway is only taken by cells already determined as melanoblasts (Mintz, 1967; Erickson and Goins, 1995) . Before the migration, the pigment cell progenitors proliferate and accumulate in a region close to the dorsal neural tube, the migration staging area (Weston, 1991) . The earliest known murine markers, Mitf (Opdecamp et al., 1997) , Dct (Steel et al., 1992) , and Kit (Motro et al., 1991) the absence of known markers make it dif®cult to study the melanocyte founders, and the molecular mechanisms underlying their determination, proliferation, migration, and differentiation are still poorly understood. In the present study, an indirect approach has been adopted, using cultured cells grafted into the chicken neural crest cell migratory pathways, to better understand these fundamental cellular mechanisms.
Sarcoma S180 cells, NIH-3T3 ®broblasts, and cells derived from the somite or the dorsal root ganglia, either do not migrate or migrate only ventrally but not in the dorsolateral pathway (Erickson et al., 1980) . To identify cells that could migrate in the dorsolateral pathway, the in vivo behavior of several cell lines were tested. In a ®rst attempt, we grafted a skin melanoblast cell line derived from mouse newborn skin, the melb-a cells (Sviderskaya et al., 1995) . The cells migrated only ventrally, showing that during their development they lost the transient ability of the melanoblast precursors to migrate in the dorsolateral pathway (data not shown). The migratory behavior displayed by ES cells appears to be unique among the different cells tested. Wild-type ES cells were able to migrate simultaneously in the ventral and the dorsolateral pathways for at least 66 h. The activation of the bHLH transcription factor Mitf suggested that the grafted wild-type ES cells were differentiating in the chicken embryo.
Mutations in the genes encoding Mitf, Kit or Dct are responsible for complete or partial lack of skin and hair melanocytes. While Kit is expressed at a high level in ES cells, Mitf and Dct are expressed at very low levels. Nevertheless, grafted ES cells migrate along the dorsolateral pathway. This suggests that expression of Mitf and Dct is not crucial at least for the onset of dorsolateral migration. This conclusion agrees with previous data showing that Kit-positive pigment cell precursors are seen along the dorsolateral migration pathway in Mitf-de®cient mice (Opdecamp et al., 1997) . It has been suggested that Mitf is responsible for an increase of Kit expression in pigment cell precursors while they migrate; this increase would stimulate their proliferation. If this hypothesis is correct, the lack of proliferation of the grafted ES cells in the chick embryo could result from the low level of Mitf expression in the ES cells. Alternatively, the phosphorylated status of Mitf may not be appropriate in ES cells. The use of ES cells carrying an overexpressed Mitf allele could possibly lead to the proliferation of grafted ES cells in the chick embryo. This hypothesis is currently under investigation. SCF, the Kit ligand, is not expressed in ES cells, thereby eliminating the possibility of an autocrine loop. In the chicken embryo, the dorsolateral migration is delayed 18 h compared to the ventral migration (Erickson et al., 1992) . The onset of endogenous Steel expression in the ectoderm occurs concomitant to the dorsolateral migration of endogenous crest cells (Lecoin et al., 1995) . However, it has been suggested that neural crest cells themselves could transiently synthesize SCF gene during their stay in the migration staging area (Guo et al., 1997) . Therefore, it is not clear if SCF is available for ES cells at the time of their initial migration. Moreover, whether the chicken SCF is able to induce a identical response following its interaction with a murine Kit receptor is unknown. Anyhow, the behavior of Kit-de®cient cells suggests that Kit is not necessary for the migration of neural crest cell at this stage. Thus, ES cells may already possess the correct set of molecules, or at least an acceptable combination of proteins, required to migrate in the ventral and dorsolateral pathways.
b 1 integrin is expressed in vivo in migrating neural crest cells (Duband et al., 1986; Krotoski et al., 1986) . In our study, the behavior of b 1 integrin-de®cient ES cells showed that b 1 integrins are differentially involved in ventral and dorsolateral migration. Although their motility was reduced, bl 2/2 ES cells were still able to migrate in the ventral pathway and this migration was qualitatively not different from that of b 1-expressing cells. In contrast, the dorsolateral migration was severely impaired. This is in agreement with previous results from chimeras obtained from normal mouse blastocysts injected with b l 2/2 ES cells. Some b l 2/2 cells were found in ventral derivatives of neural crest cells, such as the peripheral nervous system and the adrenal medulla (Fa Èssler and Meyer, 1995 2/2 ES cells were found once injected into albino blastocysts (unpublished result). Altogether, this indicates that b 1 integrin is required for the melanocyte lineage. b1 integrins bind to different matrix proteins, such as ®bronectin, laminin, collagen and vitronectin. All these substrates are present along the crest migratory pathways (Krotoski et al., 1986; Perris et al., 1993) . b 1-de®cient ES cells could still attach to ®bronectin, though less ef®ciently than b 1 expressing cells. This attachment was almost completely dependent on binding to the RGD site of ®bronectin. a 3b 1, a 5b1 and different a v-containing integrins (a vb1, a vb3, a vb5, a vb6) bind to this RGD site. However, a 5b 1 binding also requires a synergistic site located nearby (Akiyama et al., 1995) . In addition, it was recently shown that a 5b 1 could bind to another site located in the amino-terminal of ®brin domains (Hocking et al., 1998) . This could explain the difference between the b1 1/2 and b 1 2/2 cells in the inhibitory action of the RGD peptide.
Our experiments show that the integrins required for the ventral and dorsolateral migration are different. The migration into the ventral pathway can be mediated by non-b 1 integrin, such as a v containing integrins, and the migration into the dorsolateral pathway requires b 1 integrins. Among these integrins, a 5b 1 is probably important, as suggested previously (Beauvais et al., 1995) . Until now, no obvious differences have been observed in the distribution of matrix proteins along the two pathways. However, local variations in the orientation of the ®brils and/or concentrations of the components may not have been detected. Moreover, in addition to their adhesion properties, integrins cooperate with growth factors to regulate cell growth, and with cadherins to modulate cell adhesion properties.
The usefulness of combining murine ES cells with avian neural crest cells in vivo offers an attractive system because transformed ES cells carrying subtle mutations may be obtained. Indeed, several hundreds of murine ES cell lines heterozygous for null-mutations are available. If the corresponding homozygous ES cells is not available, the derivation of ES cell lines homozygous for the mutant allele is obtained using either the heterozygous ES cell line or homozygous blastocysts as starting point material. Here, we illustrated this strategy by analyzing the behavior of Kit-and b 1 integrin-de®cient ES cells in chick embryos. Our analysis brought new insights into the role of Kit and b 1 integrin in neural crest cells migration. Although, we used ES cells carrying loss-of-function mutations, the analysis of ES cells carrying gain-of-function mutations should be possible. In particular, ES cells overexpressing various proteins possibly involved in the migration of neural crest cells should be performed. One can even think of grafting gene-trapped ES cells as a screening method.
To our knowledge, we have provided the ®rst information about the speci®city of the dorsolateral pathway, and its restrictive access. The fate of the grafted cells has been examined after 2 and 3 days in the chicken embryo. The number of cells did not increased, although cells, found mainly in the dorsolateral pathway, were able to migrate and differentiate further. Therefore, we have encountered the present limit of the model. This novel way of using wild-type and mutant ES cells has already proven to be useful, and further studies will bring new information about the role of various proteins involved in the neural crest cell lineages. At the very least, these experiments shed some light on the molecular mechanisms underlying the dorsolateral migration of melanoblasts.
Experimental procedures
Antibodies and reagents
The CS hybridoma supernatant against Mitf was a gift from D.E. Fisher (Harvard Medical School, Boston, MA; Weilbaecher et al., 1998) . C19 polyclonal antibodies against Kit were purchased from Santa-Cruz (cat. no. SC-168). Rabbit antiserum against SCF, and supernatants and cell extracts of SCF-expressing COS cells were kindly provided by B. Wehrle-Haller (Centre Medical Universitaire, Geneva). Rabbit antiserum against laminin (Andre Â et al., 1994) was a gift from H. Feracci (CNRS-Institut Curie, Paris, France). RGDS peptides (Sigma, A9041) and heparin (Laboratoire Choay, Paris, France) were used according to the manufacturers' recommendations. CFSE is a¯uorescent dye that was purchased from Molecular Probes.
Cell culture and cell lines
G119 and G201 ES cell clones are heterozygous and homozygous for the b 1 integrin null allele, respectively. They were previously generated by transfection of D3 ES cells with a gene trap type vector containing a bgeo (lacZneo) fusion gene to abolish the expression of b 1 integrin (Fa Èssler and Meyer, 1995; Doetschman et al., 1985) .
Kit
/1 ES cells were derived from blastocysts according to standard procedures (Robertson, 1987; Bernex et al., 1996) . Resulting Kit W-lacZ /Kit W-lacZ , Kit W-lacZ /1 and 1/1 ES clones were tested for the presence of the lacZ gene by PCR using speci®c oligonucleotides (Hanley and Merlie, 1991) . The presence of the ®rst exon of Kit (De Sepulveda et al., 1995; GenBank no. X86451) , which is missing in the Kit W-lacZ allele, was detected by ampli®cation of a 159-bp fragment using two primers (5 H TCC TGT TGG TCC TGC TCC3 H and 5 H CCA CCT TCG AGG TGG TAG G3
H , respectively). ES cells expressing constitutively b -galactosidase were generated by electroporation of the 62 plasmid containing the bgeo chimeric (b -galactosidase±neomycin) gene under the control of the PGK promoter (Larue et al., 1996) . Various clones were produced. The clone used in the present study expressed a high amount of b -galactosidase and continued to express uniformly this marker after the differentiation of the ES cells.
The various ES cells were grown on gelatin in highglucose DMEM supplemented with 15% heat inactivated FCS, 2 mM glutamine (GIBCO-BRL, Gaithersburg, MD), 2000 U/ml mouse LIF (GIBCO-BRL), and 0.1 mM bmercaptoethanol (Sigma) in the presence of penicillin and streptomycin.
The melb-a cell line was kindly provided by D. Bennett (St. George's Hospital Medical School, London, UK). This cell line was derived from melanoblasts isolated from newborn mouse skin (Sviderskaya et al., 1995) . The melba cells were grown in RPMI supplemented with 10% FCS, 20 ng/ml SCF (Serotec, UK), and 40 pM basic FGF (a gift from H. Prats, Toulouse, France). NIH-3T3 cells were classically grown in DMEM medium containing 5% heat-inactivated FCS in the presence of penicillin and streptomycin.
Northern blot
Total RNA was prepared from cell cultures using the Roti-Quick RNA puri®cation kit (Roth). PolyA mRNA was isolated with the PolyATract mRNA isolation kit (Promega). Twenty mg of total RNA (melb-a and NIH-3T3 cells) or polyA RNA puri®ed from 800 mg of total RNA (ES cells) was separated on a 1% agarose formaldehyde gel under denaturing conditions, transferred onto a nylon membrane (Hybond-N1, Amersham) and hybridized with a 32 P-labeled probe (Maniatis et al., 1982) . The blots were hybridized with a speci®c probe for Mitf (nucleotides 84±1278), SCF (nucleotides 1±823), or GAPDH (exons 5-8).
Western blot
To prepare total cell extracts, ES cells and melb-a cells were directly lysed on a Petri dish with RIPA buffer (10 mM Tris pH 7.5, 1% Na-deoxycholate, 1% NP-40, 150 mM NaCl, 0.1% SDS, 1 mg/ml leupeptin, 100 IU aprotinin, 1 mM NaVO 4 ). The lysates were centrifuged for 5 min at 14 000 rpm and the supernatants were mixed with 1/5 volume of 5 £ Laemmli buffer. Proteins were separated on a 10% SDS±polyacrylamide gel and electrotransferred to a nitrocellulose membrane. The membrane was then incubated in blocking buffer (5% low fat milk, 0.25% Tween-20 in Tris-buffered saline). The Mitf, Kit and SCF proteins were detected with the CS monoclonal antibody (1/10 dilution in blocking buffer), C19 polyclonal antibodies (2 mg/ml diluted in blocking buffer) and a rabbit antiserum directed against SCF (1/100 dilution in blocking buffer), respectively. These proteins were visualized using secondary antibodies coupled to peroxidase and the enhanced chemiluminescence system (ECL) from Amersham.
Fluorescence labeling of cells
On day 0, the cells were trypsinized and 5 £ 10 5 ES cells were plated on a Petri dish of 60 mm diameter. On day 1, the cells were detached from the plastic with a PBS solution containing 0.25% trypsin and 1 mM EDTA (GIBCO-BRL), rinsed in ES cell culture medium and centrifuged for 5 min at 130 £ g. The cell pellet was resuspended at a density of 106 cells/ml in ES cell culture medium containing 1 m1 CFSE (10 mM stock solution in DMSO; Molecular Probes) and incubated for 45 min at 378C. The cells were then centrifuged for 5 min at 130 £ g, resuspended in 1 ml fresh culture medium and kept at 378C under 10% CO 2 in a humid atmosphere. During the grafting experiments, 50-ml aliquots of the cell suspension were transferred to bacteriological Petri dishes (diameter 35 mm, coated with 3 mg/ml BSA in PBS for 30 min at room temperature) containing 1.5 ml DMEM equilibrated at 378C. The cells were stained with 10 ml of 0.2% (w/v) Neutral Red (Sigma). The survival of the cells was routinely checked by taking samples from the bacteriological Petri dishes and plating them on a tissue culture dish containing culture medium. Cells were able to attach to the plastic and grew with normal ef®ciency. The viability of the cells was monitored for a couple of days and under these conditions, no toxicity of the CFSE-stained cells was observed.
Grafting experiments
The grafting experiments were performed essentially as previously described (Beauvais et al., 1995) , except that in this case the grafts were not only performed in vitro but also in ovo. Brie¯y, chicken embryos were incubated until they had developed 20±25 somite pairs. For in ovo experiments, 1 to 2 ml of albumin was aspirated through the shell with a syringe (gauge 25) and a window of about 2 cm in diameter was created above the blastoderm. The blastoderm was stained with a drop of Neutral Red and the vitelline membrane on the top of the embryo was opened using tungsten needles. Aggregates of approximately 20±40 ES cells were pipetted from the Petri dish onto the embryo and gently inserted between a somite and the neural tube through a slit in the ectoderm. The graft was made at the axial level where neural crest cells had just migrated off the dorsal surface of the neural tube (i.e. the ®fth last somite pairs). After grafting, the eggs were sealed with tape and incubated at 388C for about 18, 42 or 66 h. At 18 h, no difference was observed between in vitro or in ovo graftings.
Analysis of grafted embryos: confocal scanninḡ uorescence microscopy
For confocal scanning¯uorescence analysis, grafted embryos were dissected and those containing¯uorescent cells were selected using an epi¯uorescence microscope. Embryo pieces around the graft site were ®xed for 1 h in methanol at 2208C, 1 h in methanol at 48C and rehydrated. The pieces were rinsed three times in PBS, incubated overnight at 48C in PBS containing 5% FCS, then for 5 h at 48C in the presence of antibodies directed against laminin (1:500 dilution in PBS containing 5% FCS). The pieces were washed overnight in PBS at 48C, incubated for 5 h with secondary antibodies (1/50 dilution of Texas Red-conjugated anti-rabbit Ig (Amersham)) and then washed again overnight at 48C in PBS. Embryo pieces were shortened around the graft to reach a length of 2 somites. These pieces were positioned transversally on slides in a drop of mowiol. They were optically sectioned transversally with a confocal scanning¯uorescence microscope (Leica Lasertechnic, Heidelberg, Germany). Immuno¯uorescence analysis was performed using a TCS4D confocal microscope based on a DM microscope interfaced with an argon/krypton laser. Simultaneous double¯uorescence acquisitions were performed using the 488 nm and the 568 nm laser lines using a 16£ (numeric aperture 0:5) or a 40£ (numeric aperture 1 oil immersion) objectives. The¯uorescence was selected with appropriate double¯uorescence dichroic mirror and band pass ®lters and measured with blue-greensensitive and red-side-sensitive-one photomultipliers. Depths up to 160 mm can be scanned in this way, and it is therefore possible to completely examine the region of the graft and follow the migration of the grafted cells by optical slicing. This method allows the rapid screening and analysis of a large number of embryos.
Analysis of grafted embryos: histological analysis
Embryos grafted with lacZ-expressing ES cells were ®xed in PBS containing 0.25% glutaraldehyde (Sigma, cat. no. G5882), at 48C for 1 h, incubated in permeabiliza-tion buffer (2 mM MgCl 2 , 0.01% Na-deoxycholate, 0.02% NP-40 in PBS) for 30 min at RT, and then incubated overnight at 308C with slight agitation in X-gal staining solution (5 mM K 3 Fe(CN) 6 , 5 mM K 4 Fe(CN) 6 , 2 mM MgCl 2 , 0.01% Na-deoxycholate, 0.02% NP-40 in PBS, with 0.04% X-gal). The embryos were washed three times in PBS, post®xed in 4% paraformaldehyde at 48C for 2 h, washed overnight in PBS, and then dehydrated in graded alcohol, embedded in paraplast, and cut into 7-mm sections.
Adhesion assay
Bacterial dishes were coated with 50-ml drops of 10 or 50 mg/ml bovine ®bronectin diluted in PBS (Gibco) and then incubated at 378C for 1 h. The plastic was then saturated with a 3 mg/ml solution of BSA in PBS for 30 min at 378C, and then rinsed with PBS. The solution of BSA had been heat-inactivated at 808C for 3 min.
ES cells were harvested with 0.05% trypsin and 0.02% EDTA in PBS and then incubated in suspension in lowcalcium medium (SMEM with 10% dialyzed FCS (GIBCO-BRL)) for 1 h at 378C under 10% CO 2 to allow recovery from trypsin treatment and to avoid aggregation. The number of cells was determined and then centrifuged at 1000 rpm for 5 min. The pellet of cells was resuspended in DMEM in the presence or absence of RGDS peptides or heparin. Droplets of 5000 cells suspended in DMEM were seeded onto the substrates and incubated for 1 h at 378C. RGDS peptides (1 mg/ml) and heparin (100 mg/ml) were added to the suspension and immediately deposited on the substrates. Attached cells were ®xed in 3.7% formaldehyde in PBS. Three independent experiments were performed and gave similar results.
